Showing results (211-220 of 243) with videos related to
Sort By:
Pageof 25
Anticancer Research|December 3, 2024
Ivermectin Enhances Paclitaxel Efficacy by Overcoming Resistance Through Modulation of ABCB1 in Non-small Cell Lung CancerAnna Hayashi, Koichiro Kamio, Akihiko Miyanaga, et al.Lung Cancer (Amsterdam, Netherlands)|April 13, 2024
Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung CancerTakehiro Tozuka, Rintaro Noro, Hideaki Mizutani, et al.Cancer Medicine|July 31, 2020
Real-world outcomes of chemoradiotherapy for unresectable Stage III non-small cell lung cancer: The SOLUTION studyHidehito Horinouchi, Shinji Atagi, Satoshi Oizumi, et al.Lung Cancer (Amsterdam, Netherlands)|December 21, 2024
Real-world status of multimodal treatment of Stage IIIA-N2 non-small cell lung cancer in Japan: Results from the SOLUTION study, a non-interventional, multicenter cohort studyHidehito Horinouchi, Haruyasu Murakami, Hideyuki Harada, et al.Frontiers in Pharmacology|May 22, 2024
Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancerFumihiko Ando, Takeru Kashiwada, Shoko Kuroda, et al.Journal of the National Cancer Institute|August 10, 2007
Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifierMasahiro Seike, Nozomu Yanaihara, Elise D Bowman, et al.Thoracic Cancer|December 15, 2020
Functional inhibition of heat shock protein 70 by VER-155008 suppresses pleural mesothelioma cell proliferation via an autophagy mechanismKosuke Sakai, Maya Inoue, Shintaro Mikami, et al.European Journal of Cancer (Oxford, England : 1990)|December 7, 2023
A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study)Satoshi Watanabe, Naoki Furuya, Atsushi Nakamura, et al.European Journal of Cancer (Oxford, England : 1990)|March 26, 2023
Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL StudyRyota Saito, Shunichi Sugawara, Ryo Ko, et al.Surgery Today|May 10, 2002
Transanal repair of rectourethral fistula after a radical retropubic prostatectomy: report of a caseFumitake Hata, Takahiro Yasoshima, Shingo Kitagawa, et al.Pageof 25